Intangible Assets
Other
1,774,246 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets - Investments
1,947,249 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets
3,721,495 GBP2024-12-31
0 GBP2023-12-31
Debtors
2,747,109 GBP2024-12-31
2,509,169 GBP2023-12-31
Cash at bank and in hand
4,843,858 GBP2024-12-31
142 GBP2023-12-31
Current Assets
10,626,110 GBP2024-12-31
4,612,601 GBP2023-12-31
Net Current Assets/Liabilities
-399,814 GBP2024-12-31
168,275 GBP2023-12-31
Total Assets Less Current Liabilities
3,321,681 GBP2024-12-31
168,275 GBP2023-12-31
Creditors
Non-current
-1,095,968 GBP2024-12-31
Net Assets/Liabilities
2,225,713 GBP2024-12-31
32,007 GBP2023-12-31
Equity
Called up share capital
200,000 GBP2024-12-31
200,000 GBP2023-12-31
200,000 GBP2022-12-31
Other miscellaneous reserve
2,603,290 GBP2024-12-31
0 GBP2023-12-31
Retained earnings (accumulated losses)
-577,577 GBP2024-12-31
-167,993 GBP2023-12-31
137,145 GBP2022-12-31
Equity
2,225,713 GBP2024-12-31
32,007 GBP2023-12-31
337,145 GBP2022-12-31
Profit/Loss
-409,584 GBP2024-01-01 ~ 2024-12-31
-305,138 GBP2023-01-01 ~ 2023-12-31
Cash and Cash Equivalents
-1,045,020 GBP2022-12-31
Bank Overdrafts
Amounts falling due within one year
0 GBP2024-12-31
Average Number of Employees
282024-01-01 ~ 2024-12-31
292023-01-01 ~ 2023-12-31
Wages/Salaries
1,920,293 GBP2024-01-01 ~ 2024-12-31
2,285,064 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
271,507 GBP2024-01-01 ~ 2024-12-31
273,506 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
2,434,532 GBP2024-01-01 ~ 2024-12-31
2,783,997 GBP2023-01-01 ~ 2023-12-31
Investments in Subsidiaries
1,947,249 GBP2024-12-31
0 GBP2023-12-31
Finished Goods/Goods for Resale
3,035,143 GBP2024-12-31
2,103,290 GBP2023-12-31
Trade Debtors/Trade Receivables
2,305,154 GBP2024-12-31
1,868,163 GBP2023-12-31
Other Debtors
Current
59,184 GBP2024-12-31
7,241 GBP2023-12-31
Prepayments/Accrued Income
Current
192,417 GBP2024-12-31
154,379 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
0 GBP2024-12-31
0 GBP2023-12-31
Debtors
Current
2,556,755 GBP2024-12-31
2,386,870 GBP2023-12-31
Other Debtors
Non-current
190,354 GBP2024-12-31
122,299 GBP2023-12-31
Debtors
Non-current
190,354 GBP2024-12-31
122,299 GBP2023-12-31
Other Creditors
Current
403,830 GBP2024-12-31
1,108 GBP2023-12-31
Other Remaining Borrowings
Non-current
1,095,968 GBP2024-12-31
0 GBP2023-12-31
Number of Shares Issued (Fully Paid)
200,000 shares2024-12-31
200,000 shares2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
188,367 GBP2024-12-31
164,450 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
504,046 GBP2024-12-31
428,921 GBP2023-12-31
Interest Payable/Similar Charges (Finance Costs)
42,269 GBP2024-01-01 ~ 2024-12-31
60,392 GBP2023-01-01 ~ 2023-12-31
Bank Overdrafts
0 GBP2024-12-31
-1,266,465 GBP2023-12-31
NORDIC PHARMA LIMITED
InfoNORDIC PHARMACEUTICALS LIMITED - 2002-05-07
Registered number 01489084Building 1410 Arlington Business Park, Theale, Reading RG7 4SA
PRIVATE LIMITED COMPANY incorporated on 1980-04-02 (45 years 11 months). The company status is Active.
The last date of confirmation statement was made at 2025-05-04
CIF 0NORDIC PHARMA LIMITED
SRegistered number 01489084
Building 1410, Arlington Business Park, Theale, Reading, England, RG7 4SA
Limited Company in Companies House, England
CIF 1 CIF 2 NORDIC PHARMA LIMITED
SRegistered number 01489084
Building 1410, Arlington Business Park, Theale, Reading, United Kingdom, RG7 4SA
Limited Company in Companies House, England
CIF 3